CAPTRUST Financial Advisors
NMTR

CAPTRUST Financial Advisors’s 9 Meters Biopharma NMTR Stock Holding History

CAPTRUST Financial Advisors’s Portfolio NMTR Stock Details NMTR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-3,167
Closed -$14K – 2238
2022
Q3 		$14K Buy
3,167
+3,000
+1,796% +$14.9K ﹤0.01% 2024
2022
Q2 		$1K Buy
+167
New +$1.57K ﹤0.01% 4815
2022
Q1 		– Sell
-647
Closed -$13K – 5232
2021
Q4 		$13K Sell
647
-845
-57% -$18.9K ﹤0.01% 3582
2021
Q3 		$39K Sell
1,492
-4,438
-75% -$105K ﹤0.01% 2753
2021
Q2 		$130K Sell
5,930
-68
-1% -$1.67K ﹤0.01% 1825
2021
Q1 		$140K Buy
5,998
+306
+5% +$9.4K ﹤0.01% 1733
2020
Q4 		$98K Buy
5,692
+992
+21% +$16.6K ﹤0.01% 1510
2020
Q3 		$78K Buy
4,700
+700
+18% +$8.49K ﹤0.01% 1453
2020
Q2 		$58K Buy
+4,000
New +$45.1K ﹤0.01% 1571

Other funds holding NMTR

Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
LCM
Laurion Capital Management New York $2.29B AUM 75.73% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
GCP
GSA Capital Partners London, United Kingdom $1.61B AUM 28.28% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
ODFS
O'Donnell Financial Services San Rafael, California $290M AUM 15.6% 1-Year Est. Return

CAPTRUST Financial Advisors's NMTR Position: Q4 2022 in Review

CAPTRUST Financial Advisors sold out of 9 Meters Biopharma (NMTR) in Q4 2022, closing a stake of 3,167 shares — an estimated $14K sold.

CAPTRUST Financial Advisors first reported a position in NMTR in Q2 2020 and held it in 9 quarters. The position peaked at $140K in Q1 2021. 42 funds tracked by Wall St. Rank hold NMTR as of Q4 2022.

  • CAPTRUST Financial Advisors reported no remaining 9 Meters Biopharma position as of Q4 2022 after selling out during the quarter.
  • CAPTRUST Financial Advisors sold 3,167 9 Meters Biopharma shares in Q4 2022, an estimated $14K.
  • CAPTRUST Financial Advisors first reported a position in 9 Meters Biopharma in Q2 2020 and held it in 9 quarters.
  • CAPTRUST Financial Advisors's 9 Meters Biopharma position peaked at $140K in Q1 2021.
  • 42 funds tracked by Wall St. Rank held 9 Meters Biopharma as of Q4 2022.

Based on CAPTRUST Financial Advisors's 13F filing for Q4 2022, filed 15 Feb 2023.